// App-Quantinova.ai

565 : Chromosomal copy number alterations (CNAs) for risk assessment of ductal carcinoma in situ (DCIS).

Researchers

Presenter

  • Anosheh Afghahi

Principal Investigators

  • Erna Forgo

  • Aya Mitani

  • Tina Seto

  • Kristin C. Jensen

  • Scarlett Lin Gomez

  • Amar K. Das

  • Andrew H. Beck

  • Allison W. Kurian

  • Robert B. West

  • Manisha Desai

  • Sushama Varma

Medical Centers

  • Stanford School of Medicine, Stanford, CA

  • Cancer Prevention Institute of California (CPIC), Fremont, CADepartment of Pathology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CADepartment of Psychiatry and The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH

  • Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final